Fundraising Fox
Vittoria Biotherapeutics, Inc
Philadelphia, US · Founded 2021 · 4 known investors
Find your way into Vittoria Biotherapeutics, Inc
Sign up to see every warm intro you have to Vittoria Biotherapeutics, Inc
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Vittoria Biotherapeutics, Inc team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Vittoria develops immunotherapies, specifically CAR T-cell therapies, to treat difficult-to-treat diseases including cancers beyond B-cell types. The company focuses on expanding the scope and efficacy of CAR T-cell treatment for patients with limited therapeutic options.
Founders & leadership
Vittoria Biotherapeutics, Inc was founded in 2021 by Nicholas Siciliano.
Board
Investors · 4
How we know: Agent Capital's portfolio page · a partner's Signal profile · the VCSheet dataset · Not right? Tell us
How we know: BioAdvance's portfolio page · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$8.7M disclosed across 1 round · 2021
▶$8.7MraisedDec 2021 · 11 investors · BiotechnologyRule 506(b)
- Preston NoonExecutive Officer
- Geeta VemuriExecutive Officer, Director
- Nicholas SicilianoDirector
- Bruce PeacockExecutive Officer, Director
- Leon MoulderDirector
- Offering amount
- $9.2M
- Amount sold
- $8.7M
- First sale
- Jul 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Vittoria Biotherapeutics, Inc do?
- Vittoria develops immunotherapies, specifically CAR T-cell therapies, to treat difficult-to-treat diseases including cancers beyond B-cell types. The company focuses on expanding the scope and efficacy of CAR T-cell treatment for patients with limited therapeutic options.
- Who founded Vittoria Biotherapeutics, Inc?
- Vittoria Biotherapeutics, Inc was founded by Nicholas Siciliano in 2021.
- Who are Vittoria Biotherapeutics, Inc's investors?
- Vittoria Biotherapeutics, Inc's investors include Agent Capital, BioAdvance, Global BioAccess Fund, Hatch BioFund.
- How much funding has Vittoria Biotherapeutics, Inc raised?
- Vittoria Biotherapeutics, Inc has disclosed $8.7M raised across 1 round.
- Where is Vittoria Biotherapeutics, Inc headquartered?
- Vittoria Biotherapeutics, Inc is headquartered in Philadelphia, US.